LineRefine — Bring med spa patients back when their toxin actually wears off

The math nobody does

The industry celebrates the 73%. Your budget lives in the 27%.

73% of med spa patients are repeat patients. Flip the number: you lose about 1 in 4 every year. At 300 active patients, that's roughly 75 out the back door — and at the $285 median cost to acquire a new patient, about $21,000 a year in marketing spend just to maintain the status quo.

For a decade, growth forgave that leak. That era ended: when the market grows 1% and your zip code adds three competitors; retention is the whole game. You can't outspend the chains, and you shouldn't join them at $8 a unit.

73%

repeat patients looks great on paper — until you realize 27% of your client base is constantly churning.

1 in 4

patients quietly lost each year — easy to miss, but hard to afford

$21,375/yr

replacement marketing at 300 patients; zero net growth to show for it.

Same-store growth < 1% in 2025 ~1,000 new med spas every year Chains advertising $8 units

Sources: AmSpa State of the Industry 2024 (73% repeat patients); Cakesmash Media 2026 ($285 median patient acquisition cost); Beauty Independent 2025 (market growth, saturation, $8/unit chains); OptiMantra 2026 (retained injectable patient value $1,600–$2,100/yr). We only publish numbers we can source — and we'll compute yours from your own books.

Where the money goes

You see the revenue on your P&L. You’re missing the three leaks draining it.

01

The wear-off gap

Toxin fades at 12–16 weeks. The average patient rebooks at 4.8 months. That drift costs about $250 per patient per year — and no calendar reminder knows when her toxin is actually fading.

02

The recipe walks out the door

Replacing an injector runs $50K–$100K — and her book leaves with her because the doses, placement, and response history live in her head. It's not disloyalty; the patient is loyal to the only person who knows her face.

An injector with a 300-patient book who takes a third of it removes $150K–$200K of annual recurring revenue.

03

The chart you don't have — until you need it

Documented baselines and tracked results are your only real defense in a refund dispute or review threat and enforcement is rising. The same record that protects you is the one that could be earning rebookings.

New York's 2026 task-force sweep cited roughly 2 in 5 med spas inspected. Documentation done right is an asset with a yield.

Invisible on daily reports. Compounded on your annual bottom line.

How it works

The AI aesthetic record that works for you between visits.

Not another booking system. Not a blast tool. Not an arbitrary reminder. The reminder is AI-driven analysis of the patient's own face.

01

In the office

Scanned at check-in, in under two minutes.

Most patients scan at check-in, on an iPad or iPhone — no extra hardware. AI reads their facial anatomy: muscle position, movement, and wrinkle patterns, building a personal baseline for the visit.

LineRefine app guiding a patient through a facial scan, expression by expression

02

Between visits

Prompted to rescan, tracked for real effectiveness.

LineRefine prompts each patient to rescan every few weeks. AI compares each scan to their peak, tracking real effectiveness — so rebooking is triggered by an actual fade, not a fixed calendar date.

LineRefine app comparing a patient's peak results against today, side by side

03

At true wear-off

Prompted to rebook — and personalized for next time.

The patient is prompted to rebook the moment it is actually needed — never on some arbitrary calendar. AI turns actual results into a personalized reference for your injector, so every visit is personalized, not a guess.

LineRefine app showing a patient's treatment cycle progress, approaching her rebook window

04

In your practice

Your practice sees retained revenue, automatically.

Who's due, who's overdue, who's been nudged, and the revenue you're retaining per patient. That's your ROI from LineRefine, updated in real time.

Retention — this week

sorted by urgency

Sarah W. Overdue 3 wks $1,600/yr

Jane H. Nudged Jun 24 $1,250/yr

Marcus G. Due this week $980/yr

Retention view — rolling out with pilot practices.

Three pillars

Where retention turns into revenue.

01 Retention

Rebookings timed to the patient's face, not a guess.

Toxin doesn't read your reminder schedule. Somewhere around week 14 she sees movement again, and whoever reaches her in that window gets the visit. LineRefine reaches her automatically, her own scans set the timing, and the prompt arrives with your booking link.

On-time rebooking ≈ one extra visit per patient per year.

LineRefine iPad view showing a patient's treatment effectiveness declining over time, with AI analysis and recommendations for the next plan

02 Practice memory

When an injector leaves, their knowledge stays.

Doses, placement maps, response curves, and wear-off profiles live in your practice's record — not in one person's head. If a provider leaves, their replacement treats your patients like they've read the file. Because they did.

The patient relationship becomes institutional — not personal.

Treatment record — Jane Halton

Mar 2, 2026 · Glabella + forehead responded in 11 days

Nov 8, 2025 · Glabella + crow's feet wore off ~wk 15

Jul 3, 2025 · First visit baseline placement map saved

Full history available to covering injector

03 Proof of quality

Differentiation an
$8-a-unit chain can't copy.

Every discounter has before-and-afters. Almost nobody has documented analysis, planning, and tracked results across the whole cycle — proof of process that justifies your full price, and gives every patient a visible record of their own results, visit over visit.

A margin defense — not another cost line.

Early pilot data: up to 30% fewer touch-up visits — operating cost you get back.

LineRefine iPad view showing a documented treatment record with injection points mapped on the patient's face and full dosage detail

Run your own numbers

What's the leak costing you?

Our whole pitch is this math, so we publish it. Change every number to yours — the assumptions too. If your numbers don't clear breakeven, we'll tell you not to buy.

Your practice

Active toxin patients treated in the last 12 months

Average revenue per toxin visit $400–$650 is typical

Current average rebooking interval months — most practices drift to 4.5–5.5

Number of injectors

Share of patients lapsed no visit in 4.5+ months, no future booking

25%

Our assumptions — change them

These are conservative pilot targets, not observed results — we're honest about that. Set them to whatever you believe.

Patients who keep scanning between visits

60%

Rebooking interval for scanning patients months

Lapsed patients reactivated per year

20%

LineRefine cost is fixed in this model at $449 per injector per month — founding cohort $349 per injector per month. No other fees exist to hide.

Your annual leak, today

Revenue sitting in your lapsed pool$93,750

Revenue drifting away in stretched intervals$56,250

At stake per year $150,000

≈ $500 leaking per active patient per year

That's what's at stake — not what any tool recovers. Below is the conservative slice we model as recoverable.

With LineRefine — conservative

On-time rebooking revenue (scanning patients)$45,000

Lapsed patients reactivated$18,750

Replacement marketing avoided$4,275

LineRefine, all-in (2 injectors)−$10,776

Net annual gain $57,249

6.3×

return on the fee

1.8 visits/mo

covers the entire fee

Get this from your real books — free

Model notes: visits per year = 12 ÷ interval. On-time rebooking counts only patients who keep scanning between visits. Reactivated lapsed patients resume their prior cadence; each also avoids a ~$285 replacement acquisition. Benchmarks: AmSpa 2024, Cakesmash Media 2026, OptiMantra 2026. This is the same calculator we use in sales conversations — there isn't a different one.

The patient experience

Why patients keep scanning.

Patients scan because they see their own results, side by side — a personal timeline of how each treatment performs, from peak through wear-off. Their scans set the rebooking timing. The timing brings them back.

It also makes every visit feel more tailored than a discount chain ever could — an experience patients notice, and a reason to stay connected to your practice between appointments.

"In aesthetic medicine, every injection is more than the placement of a needle—it is a commitment to precision, an expression of artistry, and a promise worthy of a patient’s trust. Trust transforms a single treatment into a lifelong patient relationship."

LineRefine app showing a patient approaching her rebook window

Who built this

Founded by a leading facial plastic surgeon. Engineered by Big Tech veterans.

Dr. Keith Ladner

Co-founder, Facial Plastic Surgeon

Double board-certified facial plastic surgeon and national injectable trainer. The clinical architecture here reflects the exact protocols that built his own premier practice—so every algorithm answers to a proven master of the craft, not a software committee.

Jeff Zabel

Co-founder, CEO

Stanford d.school design engineer, serial tech founder, and former Amazon innovator. After building products scaled for millions, we’re bringing enterprise rigor and consumer-grade design to medical practices—because you deserve software you love, not software you just tolerate.

Hans Wustruck

VP Engineering

Big Tech veteran with engineering roots at Amazon and Google. Renowned for clean architecture and system reliability, he leads our core engineering—combining machine learning with strict compliance standards to build software patients and practices can trust with their data.

"Aesthetic medicine has always run on experience. LineRefine is the first instrument I've used that lets me see how my work performs over time — for every patient, every cycle."

Dr. Keith Ladner

Co-founder, Facial Plastic Surgeon

Where we are, honestly

Built in Colorado with 5 practices Physician medical direction HIPAA compliant Early data shown as early data

You've seen vendor hockey sticks. Our posture is the opposite: we publish our math, we baseline your practice from your own booking data before claiming anything, and the monthly recovered-revenue statement means you can fire us the moment the numbers stop working.

What it costs — all of it

One number. Everything included.

Start here — the 90-day proof period

$349 / injector / month

All-inclusive while we prove it — unlimited injectors and patients during the proof period.

We baseline your rebooking interval and lapsed pool from your own records first

Success criteria agreed in writing on day one

If we miss them, we refund the period. The risk is ours, not yours

After your proof period

$449 / injector / month

Founding cohort — the first 50 med spas: $349/mo per injector locked for the life of your account. Month to month, no contract.

Unlimited patient scans, monitoring, and rebooking nudges

Practice treatment records and retention view included

Monthly recovered-revenue statement: who we nudged, who rebooked, and total revenue recovered.

One recovered patient a month roughly pays the fee. Standard pricing works best >100 active toxin patients per injector — if your volume is lower, we'll adjust so your ROI stays guaranteed.

The pledge

One price. Everything included. No setup fees. No feature tiers. No long contracts. Cancel anytime. And every month we send you the recovered-revenue math — who we nudged, who rebooked, your total revenue recovered — so the fee is a receipt, not a leap of faith.

The first step is free

Find out what your leak
is actually costing you.

You don't have to believe any of this. You just have to be curious what your own number is.

1

The Retention Leak Analysis — free

Send a booking export; we send back your real rebooking interval, your lapsed patient pool, and what both are costing you. No product required. Yours to keep either way.

2

If your numbers justify it — the proof period

90 days at $349 flat. Success criteria agreed in writing, refunded if we miss them, founding rate locked for the life of your account — open to the first 50 med spas.

Book 20 minutes — we'll help you analyze your practice data and identify hidden revenue leaks or opportunities.

Your patients aren't gone. They were just never told to come back.

Your patients aren't gone. They were just never toldto come back.